Scott Taillie
Board of Directors Vice ChairScott Taillie is the General Manager of Clinical Toxicology for Abbott Laboratories, where he oversees a comprehensive portfolio and full P&L, including manufacturing, commercial operations, and strategic growth initiatives. He currently serves as Vice Chairman of NDASA, a member of its Executive and Audit Committees, and sits on the Board of Directors for the NDASA Foundation. With more than 30 years of leadership experience in the drug and alcohol testing industry, Scott has excelled in board governance, acquisitions and integrations, strategic partnerships, and market innovation. Renowned for his ability to foster industry-wide collaboration, Scott has a proven track record of driving operational excellence and advancing critical initiatives in healthcare services. His expertise in Point of Care, clinical reagents, and TPA relationships, coupled with his thought leadership as a board member, speaker, and writer, underscores his commitment to empowering employers and professionals across industries.Amid evolving challenges in the drug and alcohol testing landscape, Scott is dedicated to supporting NDASA's mission of fostering safe workplaces and communities. He remains passionate about leveraging his experience to drive meaningful progress and positive change for the association’s members in 2025 and beyond.